- Menactra Vaccine contains an active component called Meningo-coccal Polysaccharide Diphtheria Toxoid Conjugate. This vaccine is an active immunizing agent used to prevent meningococcal disease caused by neisseria meningitidis groups A, C, Y, W – 135, but it is not effective against N meningitidis serogroup B. It is contraindicated for persons who are diagnosed with Guillain-Barré Syndrome (GBS)
- it may increase the risk of GBS. Consult your doctor if you are allergic to the drug and its other ingredients.








